Correlation of Point B and Lymph Node Dose in 3D-Planned High-Dose-Rate Cervical Cancer Brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 3, 2009, Pages 803-809

  Lee, Larissa J ^a   Sadow, Cheryl A ^a   Russell, Anthony ^b   Viswanathan, Akila N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

cervical cancer; HDR brachytherapy; pelvic lymph nodes; point B

Indexed keywords

BRACHYTHERAPY; CERVICAL CANCER; CERVICAL CANCERS; COMPREHENSIVE PLANNING; CORRELATION COEFFICIENT; DOSE EQUIVALENT; DOSE-VOLUME HISTOGRAMS; HDR BRACHYTHERAPY; HIGH DOSE RATE; LYMPH NODE; PEARSON CORRELATION COEFFICIENTS; PELVIC LYMPH NODES; PELVIC NODES; POINT B; T-TESTS; TELETHERAPY; TOTAL DOSE; TREATMENT PLANNING;

BODY FLUIDS; THREE DIMENSIONAL;

POINT GROUPS;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOSIMETRY; FEMALE; HISTOGRAM; HUMAN; PELVIS LYMPH NODE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; TREATMENT PLANNING; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; LYMPH NODES; LYMPHATIC IRRADIATION; MIDDLE AGED; PELVIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS;

EID: 70349554394     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.11.052     Document Type: Article

References (16)

1. Coia L., Won M., Lanciano R., Marcial V.A., et al. The Patterns of Care Outcome Study for cancer of the uterine cervix. Results of the Second National Practice Survey. Cancer 66 (1990) 2451-2456
2. Logsdon M.D., and Eifel P.J. Figo IIIB squamous cell carcinoma of the cervix: An analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 43 (1999) 763-775
3. Tod M.C., and Meredith W.J. A dosage system for use in treatment of cancer of the uterine cervix. Br J Radiol 11 (1938) 809-824
4. Sakuragi N., Satoh C., Takeda N., et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer 85 (1999) 1547-1554
5. Fletcher G. Textbook of radiotherapy. 3rd ed (1980), Lea & Febiger, Philadelphia
6. Dose and volume specification for reporting intracavitary therapy in gynecology (Report 38) (1985), International Commission on Radiation Units and Measurements, Bethesda, MD
7. Nag S., Erickson B., Thomadsen B., et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 48 (2000) 201-211
8. Haie-Meder C., Potter R., Van Limbergen E., et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 74 (2005) 235-245
9. Potter R., Haie-Meder C., Van Limbergen E., et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 78 (2006) 67-77
10. Potter R., Dimopoulos J., Georg P., et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 83 (2007) 148-155
11. Viswanathan A.N., Dimopoulos J., Kirisits C., et al. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: Results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys 68 (2007) 491-498
12. Small Jr. W., Mell L.K., Anderson P., et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys 71 (2008) 428-434
13. Portaluri M., Bambace S., Perez C., and Angone G. A three-dimensional definition of nodal spaces on the basis of CT images showing enlarged nodes for pelvic radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 1101-1107
14. Taylor A., Rockall A.G., Reznek R.H., and Powell M.E. Mapping pelvic lymph nodes: Guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 1604-1612
15. Gebara W.J., Weeks K.J., Jones E.L., et al. Carcinoma of the uterine cervix: A 3D-CT analysis of dose to the internal, external and common iliac nodes in tandem and ovoid applications. Radiother Oncol 56 (2000) 43-48
16. Portelance L., Chao K.S., Grigsby P.W., et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 51 (2001) 261-266